Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma

BACKGROUND: Doxorubicin Transdrug (DT), a nanoformulation of doxorubicin, was demonstrated to overcome the chemoresistance of hepatocellular carcinoma (HCC) in preclinical models. Its efficacy and safety were thus investigated in phase I and randomised phase II trials in unresectable HCC. PATIENTS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Merle, Philippe, Camus, Philippe, Abergel, Armand, Pageaux, Georges Philippe, Masliah, Claude, Bronowicki, Jean Pierre, Zarski, Jean Pierre, Pelletier, Gilles, Bouattour, Mohamed, Farloux, Laetitia, Dorval, Etienne, verset, Gilles, Si-Ahmed, Si-Nafa, Doffoel, Michel, Couzigou, Patrice, Taieb, Julien, Vasseur, Bérangère, Attali, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663255/
https://www.ncbi.nlm.nih.gov/pubmed/29104762
http://dx.doi.org/10.1136/esmoopen-2017-000238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663255/
https://www.ncbi.nlm.nih.gov/pubmed/29104762
http://dx.doi.org/10.1136/esmoopen-2017-000238

Ejemplares similares